The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Resolor 2 mg film-coated tablets

Takeda Pharmaceuticals International AG Ireland BranchEU/1/09/581/002

Main Information

Trade NameResolor 2 mg film-coated tablets
Active SubstancesPrucalopride Succinate
Dosage FormFilm-coated tablet
Licence HolderTakeda Pharmaceuticals International AG Ireland Branch
Licence NumberEU/1/09/581/002

Group Information

ATC CodeA06AX Other drugs for constipation
A06AX05 prucalopride


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0122-006-003
Interchangeable List DocumentPDF of Interchangeable List
« Back